The Efficacy Evaluation of CHOLESWISE Pressed Candy on Cardiovascular Health

NCT05182788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-05-18

No results posted yet for this study

Summary

To assess the efficacy evaluation of CHOLESWISE Pressed Candy on cardiovascular disease risk factors

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo pressed candy

consume 2 tablets per day for 8 weeks

DIETARY_SUPPLEMENT

CHOLESWISE pressed candy

consume 2 tablets per day for 8 weeks

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-09
Primary Completion
2022-09-30
Completion
2023-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05182788 on ClinicalTrials.gov